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A New MHC Locus that Influences Class I Peptide Presentation
It is with deep regret that we report here that critical data in the paper by Simmons et al. (W. A.
Simmons, D. C. Roopenian, S. G. Summerfield, R. C. Jones, B. Galocha, G. J. Christianson, S. D.
Maika, M. Zhou, S. J. Gaskell, R. S. Bordoli, H. L. Ploegh, C. A. Slaughter, K. Fischer Lindahl,
R. E. Hammer, and J. D. Taurog [1997]. Immunity 7, 641±651) cannot be reproduced, and
because of this we are retracting this paper. What follows is a summary of the two types of
data contained in this paper: those that cannot be confirmed, and those that remain valid.
The data that we now believe are not valid are those shown in Figures 1, 2, 3, 5, and 6 and
Tables 1 and 2. Contrary to what was reported, the B27-restricted male-specific CTL generated
in B27 transgenic rats do not lyse B27-transgenic mouse targets in either a male-specific or
B27-specific manner, nor do they recognize the peptides described in the paper. We are
also unable to confirm the generation of HLA-B27-restricted male-specific CTL in HLA-B27
transgenic mice. We are unable to confirm any difference in the spectrum of 3H-Arg-labeled
peptides bound to HLA-B27 molecules in B27-transgenic BALB/c and BALB.B mice. There
is therefore no reproducible evidence for the main conclusion of the paper, the existence of
a ªCim2º locus near the K end of the mouse H-2 complex that influences peptide presentation.
The following data remain valid. All of the animals were produced as described. The descrip-
tions of rats and mice transgenic for rat TAP2A are valid, as are the results of peptide transport
assays in tissue extracts from rats and mice, some of which were transgenic for rat TAP2A.
We also can confirm the generation of HLA-B27-restricted male-specific CTL in HLA-B27
transgenic rats, but we do not believe that any of the data in this paper arose from valid
assays using these CTL.
The mass spectrometry analysis described in Figure 4 and in the text is valid and accurate,
but the source and biological significance of the samples analyzed are questionable.
We apologize to our colleagues for any difficulties that the publication of this paper may
have caused.
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